Killing more than 9000 Australians and costing the Australian economy more than $1 billion each year in health care expenditure, anti-microbial resistance poses a serious danger to global public health.
Through collaboration with the CSIRO and an elite panel of Australian medical researchers, Australian company Kayban has launched an effective alternative to alcohol-based products with Bio3GuardianTM.
Bio3Guardian, throughout its years of clinical R&D, is backed by an elite group of Australian Medical Researchers including Prof. Andrew Sinclair, Prof. Tom Reilly and Prof John Turnidge.
What is the story behind Kayban?
Kayban was formed in 2004 to research and develop a natural formula that had the potential to combat global antimicrobial resistance. Kayban’s product development goal was to formulate a fast acting, anti-microbial agent that is an antidote to antibiotic resistant substances such as MRSA (Methicillin Resistant Staphylococcus Aureus) and other gram positive and gram negative organisms.
The start-up has spent over a decade developing a cost-effective, consistent method for extracting the crucial alpha-linolenic acid from organic flaxseed. When combined with tea tree oil, the naturally derived formula has a powerful and synergistic effect on organisms.
Bio3Guardian can reduce the colonisation of gram-positive and gram-negative organisms, representing a breakthrough in infection control. Whilst common infections develop a tolerance to frequently used antibiotics and antiseptics, Bio3Guardian’s unique triple bonded molecular structure, and ability to consistently break down the cell walls of mutating organisms, ensures resistance is minimised.
Why is Kayban using Bio3Guardian?
Frank Palermo, a Director of Kayban, confirms Bio3Guardian is a better way to prevent the spread of infection saying, “Our products are fast acting and effective against superbugs such as golden staph (Staphylococcus aureus).”
“Bio3Guardian contains a unique natural antimicrobial formula instead of ethanol (alcohol) – aimed to kill bacteria while leaving good essential bacteria intact and not compromising skin integrity.
“The formula is actually moisturising, as opposed to ethanol-based products that can cause skin to dry and crack with repeated use. It also has a long-lasting effect, acting as a barrier on skin.”
Given the non-drying properties, tested with members of Eczema Association of Australasia, Bio3Guardian products will have immense benefit to nurses, doctors and patients in hospitals and aged care homes, additional to the many other individuals who routinely use disinfectants to maintain hygiene.
Bio3Guardian range includes an antimicrobial hand wash, an antimicrobial body wash and an antimicrobial moisturising lotion. The range is being further developed with wound care products in the pipeline.